Mutations of the BRAF gene in human cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2002-06-09

AUTHORS

Helen Davies, Graham R. Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J. Garnett, William Bottomley, Neil Davis, Ed Dicks, Rebecca Ewing, Yvonne Floyd, Kristian Gray, Sarah Hall, Rachel Hawes, Jaime Hughes, Vivian Kosmidou, Andrew Menzies, Catherine Mould, Adrian Parker, Claire Stevens, Stephen Watt, Steven Hooper, Rebecca Wilson, Hiran Jayatilake, Barry A. Gusterson, Colin Cooper, Janet Shipley, Darren Hargrave, Katherine Pritchard-Jones, Norman Maitland, Georgia Chenevix-Trench, Gregory J. Riggins, Darell D. Bigner, Giuseppe Palmieri, Antonio Cossu, Adrienne Flanagan, Andrew Nicholson, Judy W. C. Ho, Suet Y. Leung, Siu T. Yuen, Barbara L. Weber, Hilliard F. Seigler, Timothy L. Darrow, Hugh Paterson, Richard Marais, Christopher J. Marshall, Richard Wooster, Michael R. Stratton, P. Andrew Futreal

ABSTRACT

Cancers arise owing to the accumulation of mutations in critical genes that alter normal programmes of cell proliferation, differentiation and death. As the first stage of a systematic genome-wide screen for these genes, we have prioritized for analysis signalling pathways in which at least one gene is mutated in human cancer. The RAS–RAF–MEK–ERK–MAP kinase pathway mediates cellular responses to growth signals1. RAS is mutated to an oncogenic form in about 15% of human cancer. The three RAF genes code for cytoplasmic serine/threonine kinases that are regulated by binding RAS1,2,3. Here we report BRAF somatic missense mutations in 66% of malignant melanomas and at lower frequency in a wide range of human cancers. All mutations are within the kinase domain, with a single substitution (V599E) accounting for 80%. Mutated BRAF proteins have elevated kinase activity and are transforming in NIH3T3 cells. Furthermore, RAS function is not required for the growth of cancer cell lines with the V599E mutation. As BRAF is a serine/threonine kinase that is commonly activated by somatic point mutation in human cancer, it may provide new therapeutic opportunities in malignant melanoma. More... »

PAGES

949-954

Journal

TITLE

Nature

ISSUE

6892

VOLUME

417

Related Patents

  • Inhibitors Of C-Jun-N-Terminal Kinase (Jnk)
  • Rnai Probes Targeting Cancer-Related Proteins
  • Raf Kinase Modulator Compounds And Methods Of Use Thereof
  • Raf Kinase Modulator Compounds And Methods Of Use Thereof
  • Delivery, Engineering And Optimization Of Tandem Guide Systems, Methods And Compositions For Sequence Manipulation
  • Recurrent Gene Fusions In Prostate Cancer
  • Methods For Treating Cancer By Administration Of Nucleic Acids Encoding Fap And Cancer Antigens
  • Micrornas 206 And 21 Cooperate To Promote Ras-Extracellular Signal-Regulated Kinase Signaling By Suppressing The Translation Of Rasa1 And Spred1
  • Compounds And Compositions As Kinase Inhibitors
  • 1-(5-Tert-Butyl-2-Phenyl-2h-Pyrazol-3-Yl)-3-[2-Fluoro-4-(1-Methyl-2-Oxo-2,3-Dihydro-1h-Imidazo[4,5-B]Pyridin-7-Yloxy)-Phenyl]-Urea And Related Compounds And Their Use In Therapy
  • Cancer Treatments Using Combinations Of Cdk And Erk Inhibitors
  • Hydrophobically Tagged Small Molecules As Inducers Of Protein Degradation
  • Mirna And Its Diagnostic And Therapeutic Uses In Diseases Or Conditions Associated With Melanoma, Or In Diseases Or Conditions Associated With Activated Braf Pathway
  • Methods And Compositions Related To A Braf Mutation And Microsatellite Stability
  • Sulfonamido Derivatives Of 3,4-Diarylpyrazoles As Protein Kinase Inhibitors
  • Methods Of Treating Gastrointestinal Stromal Tumors
  • Cancer Treatment Using Combinations Of Erk And Raf Inhibitors
  • Raf Gene Fusions
  • Belvarafenib For Use In Treatment Of Brain Cancers
  • Methods For Determining And Inhibiting Rheumatoid Arthritis Associated With The Braf Oncogene In A Subject
  • Hydrophobically Tagged Janus Kinase Inhibitors And Uses Thereof
  • Antitumor Agent For Thyroid Cancer
  • Such As N-Butyl-2-(4-(4-Chloro-3-Methoxyphenyl)-5-Pyridin-4-Yl-1h-Imidazole-2 -Yl)Isobutylamide For Treatment Of Neurotraumatic Disorders
  • Synthesis Of Imidazooxazole And Imidazothiazole Inhibitors Of P38 Map Kinase
  • Compounds And Compositions As Protein Kinase Inhibitors
  • Anti-Cancer Compositions And Methods
  • Treatment Of Cancer By Inhibition Of Igfbps And Clusterin
  • {1-Methyl-5-[2-(5-Trifluoromethyl-1h-Imidazol-2-Yl)-Pyridin-4-Yloxy]-1h-Benzoimidazol-2-Yl}-(4-Trifluoromethyl-Phenyl)-Amine; Inhibitors Of Kinase/ Raf Kinase Activity Associated With Tumorigenesis, Serine/Threonine Kinase Or Receptor Tyrosine Kinase; Cancer; Tumors; Inhibitmapk Signaling Pathway
  • Method For Predicting The Resistance Of Melanoma To A Treatment With A Braf Inhibitor
  • Methods Of Treating Gastrointestinal Stromal Tumors
  • {1-Methyl-5-[2-(5-Trifluoromethyl-1h-Imidazol-2-Yl)-Pyridin-4-Yloxy]-1h-Benzoimidazol-2-Yl}-(4-Trifluoromethyl-Phenyl)-Amine; Inhibitors Of Kinase/Raf Kinase Activity Associated With Tumorigenesis, Serine/Threonine Kinase Or Receptor Tyrosine Kinase; Cancer; Tumors; Inhibit Mapk Signaling Pathway
  • Amorphous Form Of Quinoline Derivative, And Method For Producing Same
  • Pyrido[2,3-B]Pyrazin-8-Substituted Compounds And Their Use
  • Methods And Compositions For Treating Non-Erk Mapk Pathway Inhibitor-Resistant Cancers
  • Pharmacy Preparation For Malignant Melanoma Treatment
  • Full Length Kinase Activity-Conformation Reporter
  • Methods Of Treating Gastrointestinal Stromal Tumors
  • Pharmaceutical Compositions Of 4-(3-Chloro-4-(Cyclopropylaminocarbonyl)Aminophenoxy)-7-Methoxy-6-Quinolinecarboxamide
  • Substituted Benzimidazoles And Methods Of Their Use
  • Recurrent Gene Fusions In Prostate Cancer
  • Means And Methods For Diagnosing Cancer Using An Antibody Which Specifically Binds To Braf V600e
  • Method For Assay On The Effect Of Vascularization Inhibitor
  • Agents Enhancing Hur/Elav Protein Levels For Use In The Treatment Of Braf-Mutated Cancers
  • 1,6-Disubstituted Indole Compounds As Protein Kinase Inhibitors
  • Compounds And Compositions As Protein Kinase Inhibitors
  • Pyrido[2,3-B]Pyrazin-8-Substituted Compounds And Their Use
  • Full Length Kinase Activity-Conformation Reporter
  • Cancer Treatments Using Combinations Of Cdk And Erk Inhibitors
  • Pyrido [2,3-D] Pyrimidines And Their Use As Kinase Inhibitors
  • Bacterial Toxins And Uses Thereof As Ras Specific Proteases For Treating Cell Proliferation Diseases And Disorders
  • Anti-Fgfr3 Antibodies And Methods Using Same
  • Kinase Inhibitors Useful For The Treatment Of Proliferative Diseases
  • Methods Of Treating Resistant Cancers
  • Diagnostic Test System For Specific, Sensitive And Reproducible Detection Of Circulating Nucleic Acids In Whole Blood
  • Composition For Treating And/Or Diagnosing Colorectal Cancer, And Use Therefor
  • For Treatment Of Melanoma, Colon Cancer, And/Or Breast Cancer
  • Substituted Pyrimidinylpyrrolopyridinone Derivatives, Process For Their Preparation And Their Use As Kinase Inhibitors
  • Pyrido[2,3-B]Pyrazin-8-Substituted Compounds And Their Use
  • Inhibitors Of Cyclin-Dependent Kinases
  • High-Purity Quinoline Derivative And Method For Manufacturing Same
  • Method For Assay On The Effect Of Vascularization Inhibitor
  • Hydrophobically Tagged Small Molecules As Inducers Of Protein Degradation
  • Anti-Fgfr3 Antibodies And Methods Using Same
  • Compositions, Kits, And Methods For Identification, Assessment, Prevention And Treatment Of Pancreatic Adenocarcinoma In Humans
  • Crispr Enzyme Mutations Reducing Off-Target Effects
  • Recurrent Gene Fusions In Prostate Cancer
  • Host Cell Kinases As Targets For Antiviral Therapies Against Hcv Infection
  • Method Of Screening For Lrrk2-Related Parkinsonism Inheritance
  • 1-(5-Tert-Butyl-2-Aryl-Pyrazol-3-Yl)-3-[2-Fluoro-4-[(3-Oxo-4h-Pyrido [2, 3-B]Pyrazin- 8-Yl)Oxy]Phenyl]Urea Derivatives As Raf Inhibitors For The Treatment Of Cancer
  • Safe Sequencing System
  • Methods Of Treating Melanoma
  • High-Purity Quinoline Derivative And Method For Manufacturing Same
  • Inhibitors Of C-Jun-N-Terminal Kinase (Jnk)
  • Method To Treat Melanoma In Braf Inhibitor-Resistant Subjects
  • Pyrido[2,3-B]Pyrazin-8-Substituted Compounds And Their Use
  • Dihydronaphthyridines And Related Compounds Useful As Kinase Inhibitors For The Treatment Of Proliferative Diseases
  • Therapeutic Agent For Tumor
  • Heteroaromatic Compounds Useful For The Treatment Of Proliferative Diseases
  • Compounds And Compositions As Protein Kinase Inhibitors
  • Derivatives Of Pyrazolophenyl-Benzenesulfonamide Compounds And Use Thereof As Antitumor Agents
  • Anti-Fgfr3 Antibodies And Methods Using Same
  • 1-(5-Tert-Butyl-2-Aryl-Pyrazol-3-Yl)-3-[2-Fluoro-4-[(3-Oxo-4h-Pyrido[2,3-B]Pyrazin-8-Yl)Oxy]Phenyl]Urea Derivatives As Raf Inhibitors For The Treatment Of Cancer
  • Utility Of B-Raf Dna Mutation In Diagnosis And Treatment Of Cancer
  • Treatment Of Cancer Involving Mutated Kras Or Braf Genes
  • Safe Sequencing System
  • Biaryl Amide Compounds As Kinase Inhibitors
  • Methods And Compositions For Treating Melanoma
  • Raf Gene Fusions
  • Insulin-Like Growth Factor Binding Protein 7 For Treatment Of Cancer
  • Methods Of Identifying Responses To Map Kinase Inhibition Therapy
  • Inhibitors Of Cyclin-Dependent Kinases
  • 6-Carboaryl-Oxy-Pyrazin-2-Yl-Carboaryl-Amines And Compositions Comprising Said Compounds
  • Polycyclic Inhibitors Of Cyclin-Dependent Kinase 7 (Cdk7)
  • Rnai Probes Targeting Cancer-Related Proteins
  • Benzene Sulfonamide Thiazole And Oxazole Compounds
  • Biomarkers For Predicting And Assessing Responsiveness Of Thyroid And Kidney Cancer Subjects To Lenvatinib Compounds
  • Raf Inhibitor Compounds
  • Cancer Treatment Using Combinations Of Erk And Raf Inhibitors
  • Mipol1-Etv1 Gene Rearrangements
  • Compounds And Compositions As Protein Kinase Inhibitors
  • Utility Of B-Raf Dna Mutation In Diagnosis And Treatment Of Cancer
  • Safe Sequencing System
  • Biaryl Amide Compounds As Kinase Inhibitors
  • Inhibitors Of Cyclin-Dependent Kinase 7 (Cdk7)
  • Multimodal Cancer Therapy Comprising Chimeric Viral/Nonviral Nanoparticles And Anticancer Agents
  • Compositions Of 1-(4-Bromo-5-(1-Ethyl-7-(Methylamino)-2-Oxo-1,2-Dihydro-1,6-Naphthyridin-3-Yl)-2-Fluorophenyl)-3-Phenylurea
  • Rnai Probes Targeting Cancer-Related Proteins
  • Biomarkers For Predicting And Assessing Responsiveness Of Endometrial Cancer Subjects To Lenvatinib Compounds
  • Insulin-Like Growth Factor Binding Protein 7 For Treatment Of Cancer
  • Compositions And Methods For Identifying Transforming And Tumor Suppressor Genes
  • Cancer Treatments Using Combinations Of Cdk And Erk Inhibitors
  • Azaindolizines And Methods Of Use
  • Pharmaceutical Formulations Of (S)-Methyl(1-((4-(3-(5-Chloro-2-Fluoro-3-(Methylsulfonamido)Phenyl)-1-Isopropyl-1h-Pyrazol-4-Yl)Pyrimidin-2-Yl)Amino)Propan-2-Yl)Carbamate
  • Mirna And Its Diagnostic And Therapeutic Uses In Diseases Or Conditions Associated With Melanoma , Or In Diseases Or Conditions With Activated Braf Pathway
  • Benzene Sulfonamide Thiazole And Oxazole Compounds
  • Dehydroacetic Acid (Dhaa) And Derivative For Uses In Treating Cancer
  • Antitumor Agent Using Compounds Having Kinase Inhibitory Effect In Combination
  • P13k Pathway Mutations In Cancer
  • Purinylpyridinylamino-2,4-Difluorophenyl Sulfonamide Derivative, Pharmaceutically Acceptable Salt Thereof, Preparation Method Thereof, And Pharmaceutical Composition With Inhibitory Activity Against Raf Kinase, Containing Same As Active Ingredient
  • Dihydropyridopyrimidinyl, Dihydronaphthyidinyl And Related Compounds Useful As Kinase Inhibitors For The Treatment Of Proliferative Diseases
  • 1,3,6-Substituted Indole Derivatives Having Inhibitory Activity For Protein Kinase
  • Indazole Derivatives Or Pharmaceutically Acceptable Salts Thereof As Protein Kinase Inhibitors For Proliferative Diseases Treatment, And A Pharmaceutical Composition Containing The Same As An Active Ingredient
  • Recurrent Gene Fusions In Prostate Cancer
  • High-Purity Quinoline Derivative And Method For Manufacturing Same
  • Agents Enhancing Hur/Elav Protein Levels For Use In The Treatment Of Braf-Mutated Cancers
  • Methods For Detection Of The Oncogenic T1796a B-Raf Mutation
  • Utility Of B-Raf Dna Mutation In Diagnosis And Treatment Of Cancer
  • Multikinase Inhibitors For Use In The Treatment Of Cancer
  • Genes
  • 8-Anilinoimidazopyridines And Their Use As Anti-Cancer And/Or Anti-Inflammatory Agents
  • Anti-Cancer Compositions And Methods
  • 2-(3-Aminoaryl) Amino-4-Aryl-Thiazoles And Their Use As C-Kit Inhibitors
  • C-Raf Mutants That Confer Resistance To Raf Inhibitors
  • Imidazooxazole Derivative Having Antitumor Effect, And Pharmaceutical Composition Including Same
  • Bone Marrow On X Chromosome Kinase (Bmx) Inhibitors And Uses Thereof
  • Assaying Ovarian Cyst Fluid
  • Imidazooxazole Derivative Having Antitumor Effect, And Pharmaceutical Composition Including Same
  • Anti-Fgfr3 Antibodies And Methods Using Same
  • Methods And Systems For Detecting Genetic Mutations
  • Multikinase Inhibitors For Use In The Treatment Of Cancer
  • Imidazo[4, 5-B]Pyridin-2-One And Oxazolo[4, 5-B] Pyridin-2-One Compounds And Analogs Thereof As Cancer Therapeutic Compounds
  • E.G. 3-{5-[2-({(3r)-1-[(4-Chlorophenyl)Sulfonyl]Piperidin-3-Yl}Amino)Pyrimidin-4-Yl]Imidazo[2,1-B][1,3]Thiazol-6-Yl}Phenyl Carbamate; Antiproliferative, Anticarcinogenic Agent; Cell Proliferative Disorders
  • Compounds For The Treatment Of Braf-Associated Diseases And Disorders
  • 3-({4-[1-(2,2-Difluoroethyl)-3-(1h-Pyrrolo[2,3-B]Pyridin-5-Yl)-1h-Pyrazol-4-Yl]Pyrimidin-2-Yl}Amino)Propanenitrile, Used As Serine/Threonine Protein Kinase Inhibitors, For The Treatment Of Disease States Associated With Abnormal Cell Growth Such As Cancer
  • Treatment Of Cancer By Inhibition Of Igfbps And Clusterin
  • Mipol1-Etv1 Gene Rearrangements
  • Diagnosis Of Melanoma By Nucleic Acid Analysis
  • Compounds And Compositions As Protein Kinase Inhibitors
  • 2-(3-Aminoaryl) Amino-4-Aryl-Thiazoles And Their Use As C-Kit Inhibitors
  • Oncogenic Ras-Specific Cytotoxic Compound And Methods Of Use Thereof
  • Methods For Prognosing The Ability Of A Zearalenone Analog Compound To Treat Cancer
  • Method Of Treating Colorectal Cancer By Administration Of Pharmaceutical Formulations Of (S)-Methyl (1-((4-(3-(5-Chloro-2-Fluoro-3-(Methylsulfonamido)Pheny1)-1-Isopropyl-1h-Pyrazol-4-Yl)Pyrimidin-2-Yl)Amino)Propan-2-Yl) Carbamate
  • Pyrido[2,3-B]Pyrazin-8-Substituted Compounds And Their Use
  • Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Targeting Disorders And Diseases Using Viral Components
  • Compositions And Methods Of Use Of Crispr-Cas Systems In Nucleotide Repeat Disorders
  • Methods Of Treating Gastrointestinal Stromal Tumors
  • Anti-Cancer Compositions And Methods
  • Crispr-Cas Systems, Crystal Structure And Uses Thereof
  • Compounds And Compositions As Protein Kinase Inhibitors
  • Pharmaceutical Formulations Of (S)-Methyl (1-((4-(3-(5-Chloro-2-Fluoro-3-(Methylsulfonamido)Phenyl)-1-Isopropyl-1h-Pyrazol-4-Yl)Pyrimidin-2-Yl)Amino)Propan-2-Yl)Carbamate
  • Mipol1-Etv1 Gene Rearrangements
  • Biaryl Amide Compounds As Kinase Inhibitors
  • Polynucleotide Or Complement Comprising Nucleic Acid Sequence Flanked By First And Second Inverted Repeats
  • Polynucleotide
  • Belvarafenib For Use In Cancer Treatment
  • Inhibitors Of Cyclin-Dependent Kinase 7 (Cdk7)
  • Raf Kinase Modulator Compounds And Methods Of Use Thereof
  • Coumarin-Like Cyclic Compound As Mek Inhibitor And Use Thereof
  • High-Purity Quinoline Derivative And Method For Manufacturing Same
  • Imidazo[4,5-B]Pyridin-2-One And Oxazolo[4,5-B]Pyridin-2-One Compounds And Analogs Thereof As Therapeutic Compounds
  • 3-Arylamino Pyridine Derivatives
  • Compounds And Compositions As Protein Kinase Inhibitors
  • Methods For Treating Melanoma Using Small Molecules
  • Pyridine Derivative Inhibiting Raf Kinase And Vascular Endothelial Growth Factor Receptor, Method For Preparing Same, Pharmaceutical Composition Containing Same, And Use Thereof
  • Therapeutic Combinations Comprising A Raf Inhibitor For Use In Treating Braf Mutant Nsclc
  • 3-Arylamino Pyridine Derivatives
  • Process For The Preparation Of 8-(4-Aminophenoxy)-4h-Pyrido[2,3-B]Pyrazin-3-One Derivatives
  • Methods Of Treating Gastrointestinal Stromal Tumors
  • Biaryl Amide Compounds As Kinase Inhibitors
  • Treatments For Inhibiting Development And Progression Of Nevi And Melanoma Having Braf Mutations
  • Anti-Fgfr3 Antibodies And Methods Using Same
  • Benzene Sulfonamide Thiazole And Oxazole Compounds
  • Recurrent Gene Fusions In Prostate Cancer
  • Detection Of Braf V600e Mutation By Allele Specific Real Time Quantitative Pcr (As-Qpcr) Using Locked Nucleic Acids Primers And Beacon Probes
  • Substituted Benzazoles And Methods Of Their Use As Inhibitors Of Raf Kinase
  • Benzene Sulfonamide Thiazole And Oxazole Compounds
  • Inhibitors Of Cyclin-Dependent Kinases
  • 1-(5-Tert-Butyl-2-Phenyl-2h-Pyrazol-3-Yl)-3-[2-Fluoro-4-(1-Methyl-2-Oxo-2,3-Dihydro-1h-Imidazo[4,5-B]Pyridin-7-Yloxy)-Phenyl]-Urea And Related Compounds And Their Use In Therapy
  • Substituted Pyrimidinylpyrrolopyridinone Derivatives, Process For Their Preparation And Their Use As Kinase Inhibitors
  • Biomarkers For Melanoma
  • Methods And Compositions For Treating Non-Erk Mapk Pathway Inhibitor-Resistant Cancers
  • Use Of Microvesicles In Diagnosis, Prognosis, And Treatment Of Medical Diseases And Conditions
  • Treatment Of Cancer Involving Mutated Kras Or Braf Genes
  • Anti-Fgfr3 Antibodies And Methods Using Same
  • Inhibitors Of Cyclin-Dependent Kinase 7 (Cdk7)
  • Method For Suppressing Bitterness Of Quinoline Derivative
  • Methods Of Diagnosing And Treating Cancer In Patients Having Or Developing Resistance To A First Cancer Therapy
  • Cancer Treatment Using Combinations Of Erk And Raf Inhibitors
  • Erk1 And Erk2 Mutations That Confer Resistance To Mapk Pathway Inhibitors
  • Anti-Fgfr3 Antibodies And Methods Using Same
  • Anti-Fgfr3 Antibodies And Methods Using Same
  • Inhibitors Of Cyclin-Dependent Kinase 7 (Cdk7)
  • Erk1 And Erk2 Mutations That Confer Resistance To Mapk Pathway Inhibitors
  • Improved Methods For The Selection Of Patients For Pd-1 Or B7-H4 Targeted Therapies, And Combination Therapies Thereof
  • Biaryl Amide Compounds As Kinase Inhibitors
  • Recurrent Gene Fusions In Prostate Cancer
  • Combination Therapy Of Transcription Inhibitors And Kinase Inhibitors
  • Braf Mutation T1796a In Thyroid Cancers
  • Lrrk2 Polynucleotides
  • Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Sequence Manipulation And Therapeutic Applications
  • Treatment Of Cancer By Inhibition Of Igfbps And Clusterin
  • Treatment Of Cancer By Inhibition Of Igfbp's And Clusterin
  • 1-(5-Tert-Butyl-2-Phenyl-2h-Pyrazol-3-Yl)-3-[2-Fluoro-4-(1-Methyl-2-Oxo-2,3-Dihydro-1h-Imidazo[4,5-B]Pyridin-7-Yloxy)-Phenyl]-Urea And Related Compounds And Their Use In Therapy
  • Method Of Treating A Proliferative Disease
  • Anti-Cancer Compositions And Methods
  • 3,4-Diarylpyrazoles As Protein Kinase Inhibitors
  • Functional Genomics Using Crispr-Cas Systems, Compositions Methods, Screens And Applications Thereof
  • Method Of Treating Melanoma By Administration Of Pharmaceutical Formulations Of (S)-Methyl (1-((4-(3-(5-Chloro-2-Fluoro-3-(Methylsulfonamido)Phenyl)-1-Isopropyl-1h-Pyrazol-4-Yl)Pyrimidin-2-Yl)Amino)Propan-2-Yl)Carbamate
  • Diagnosis Of Melanoma And Solar Lentigo By Nucleic Acid Analysis
  • Thiazolylphenyl-Benzenesulfonamido Derivatives As Kinase Inhibitors
  • Recurrent Gene Fusions In Prostate Cancer
  • Methods, Models, Systems, And Apparatus For Identifying Target Sequences For Cas Enzymes Or Crispr-Cas Systems For Target Sequences And Conveying Results Thereof
  • Treatment Of Cancer By Inhibition Of Igfbps And Clusterin
  • Recurrent Gene Fusions In Prostate Cancer
  • Compounds And Compositions As Kinase Inhibitors
  • 1,3,6-Substituted Indole Derivatives Having Inhibitory Activity For Protein Kinase
  • Inhibitors Of P38 And Methods Of Using The Same
  • Tert Promoter Mutations In Cancer
  • Utility Of Ret Mutant In Diagnosis And Treatment Of Melanoma
  • 3-Arylamino Pyridine Derivatives
  • Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Genome Editing
  • Autophagy Inhibitors
  • Anti-Cancer Compositions And Methods
  • Raf Inhibitor Compounds
  • Recurrent Gene Fusions In Prostate Cancer
  • 3-Arylamino Pyridine Derivatives
  • For Injectable Solutions; Mrna Translation/Degradation Control
  • 1-(5-Tert-Butyl-2-Phenyl-2h-Pyrazol-3-Yl)-3-[2-Fluoro-4-(1-Methyl-2-Oxo-2,3-Dihydro-1h-Imidazo[4,5-B]Pyridin-7-Yloxy)-Phenyl]-Urea And Related Compounds And Their Use In Therapy
  • Methods And Compositions For Treating Cancer
  • Anti-Fgfr3 Antibodies And Methods Using Same
  • Anti-Dll3 Antibodies And Drug Conjugates For Use In Melanoma
  • Janus Kinase Inhibitors And Uses Thereof
  • Amorphous Kinase Inhibitor Formulations And Methods Of Use Thereof
  • Ccl18 And Ccl3 Methods And Compositions For Detecting And Treating Cancer
  • Drug Combinations With Substituted Diaryl Ureas For The Treatment Of Cancer
  • Site-Specific Antibody Conjugation Methods And Compositions
  • Combination Of Anti-Angiogenic Substance And Anti-Tumor Platinum Complex
  • Anticancer Combination Of A Cbp/Catenin Inhibitor And An Immune Checkpoint Inhibitor
  • Compounds And Compositions As Protein Kinase Inhibitors
  • Safe Sequencing System
  • Methods For Treatment Of Melanoma
  • Raf Gene Fusions
  • Insulin-Like Growth Factor Binding Protein 7 For Treatment Of Cancer
  • Such As {1-Methyl-5-[2-(5-Trifluoromethyl-1h-Imidazol-2-Yl)-Pyridin-4-Yloxy]-1h-Benzoimidazol-2-Yl}-(4-Trifluoromethyl-Phenyl)-Amine Via Reduction, Desulfurization; For Treating Kinase Mediated Disorders
  • Recurrent Gene Fusions In Prostate Cancer
  • Anti-Fgfr3 Antibodies And Methods Using Same
  • Agents Enhancing Hur/Elav Protein Levels For Use In The Treatment Of Braf-Mutated Cancers
  • Image Differentiated Multiplex Assays For Multiplex Detection Of Dna Mutations
  • Combination Of Braf Inhibitor, Talimogene Laherparepvec, And Immune Checkpoint Inhibitor For Use In The Treatment Cancer (Melanoma)
  • Cd99 Inhibitors And Their Uses
  • Rnai Probes Targeting Cancer-Related Proteins
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/nature00766

    DOI

    http://dx.doi.org/10.1038/nature00766

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1023536940

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/12068308


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biochemistry and Cell Biology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Genetics", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "3T3 Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Amino Acid Sequence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Base Sequence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Division", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Transformation, Neoplastic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA Mutational Analysis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Enzyme Activation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "MAP Kinase Signaling System", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Melanoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mitogen-Activated Protein Kinases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Molecular Sequence Data", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mutation, Missense", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Protein Structure, Tertiary", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Proto-Oncogene Proteins B-raf", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Proto-Oncogene Proteins c-raf", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tumor Cells, Cultured", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "ras Proteins", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Davies", 
            "givenName": "Helen", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bignell", 
            "givenName": "Graham R.", 
            "id": "sg:person.0641077014.15", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641077014.15"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cox", 
            "givenName": "Charles", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Stephens", 
            "givenName": "Philip", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Edkins", 
            "givenName": "Sarah", 
            "id": "sg:person.0744515657.65", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744515657.65"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Clegg", 
            "givenName": "Sheila", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Teague", 
            "givenName": "Jon", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Woffendin", 
            "givenName": "Hayley", 
            "id": "sg:person.01340070130.03", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340070130.03"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Research UK Centre for Cell and Molecular Biology, Chester Beatty Labs, Institute of Cancer Research, SW3 6JB, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Cancer Research UK Centre for Cell and Molecular Biology, Chester Beatty Labs, Institute of Cancer Research, SW3 6JB, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Garnett", 
            "givenName": "Mathew J.", 
            "id": "sg:person.01110741774.63", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110741774.63"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bottomley", 
            "givenName": "William", 
            "id": "sg:person.0653604740.05", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653604740.05"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Davis", 
            "givenName": "Neil", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Dicks", 
            "givenName": "Ed", 
            "id": "sg:person.01235133752.67", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235133752.67"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ewing", 
            "givenName": "Rebecca", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Floyd", 
            "givenName": "Yvonne", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gray", 
            "givenName": "Kristian", 
            "id": "sg:person.0666455053.98", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666455053.98"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hall", 
            "givenName": "Sarah", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hawes", 
            "givenName": "Rachel", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hughes", 
            "givenName": "Jaime", 
            "id": "sg:person.0744552267.05", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744552267.05"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kosmidou", 
            "givenName": "Vivian", 
            "id": "sg:person.01156170354.76", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156170354.76"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Menzies", 
            "givenName": "Andrew", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mould", 
            "givenName": "Catherine", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Parker", 
            "givenName": "Adrian", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Stevens", 
            "givenName": "Claire", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Watt", 
            "givenName": "Stephen", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Research UK Centre for Cell and Molecular Biology, Chester Beatty Labs, Institute of Cancer Research, SW3 6JB, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Cancer Research UK Centre for Cell and Molecular Biology, Chester Beatty Labs, Institute of Cancer Research, SW3 6JB, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hooper", 
            "givenName": "Steven", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Research UK Centre for Cell and Molecular Biology, Chester Beatty Labs, Institute of Cancer Research, SW3 6JB, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Cancer Research UK Centre for Cell and Molecular Biology, Chester Beatty Labs, Institute of Cancer Research, SW3 6JB, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wilson", 
            "givenName": "Rebecca", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Section of Cancer Genetics, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Section of Cancer Genetics, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jayatilake", 
            "givenName": "Hiran", 
            "id": "sg:person.01032251502.18", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032251502.18"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pathology, Western Infirmary, University of Glasgow, S11 6NT, UK", 
              "id": "http://www.grid.ac/institutes/grid.412947.d", 
              "name": [
                "Department of Pathology, Western Infirmary, University of Glasgow, S11 6NT, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gusterson", 
            "givenName": "Barry A.", 
            "id": "sg:person.0677171015.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677171015.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Section of Molecular Carcinogenesis, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Section of Molecular Carcinogenesis, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cooper", 
            "givenName": "Colin", 
            "id": "sg:person.0775127652.18", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775127652.18"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Section of Molecular Carcinogenesis, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Section of Molecular Carcinogenesis, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Shipley", 
            "givenName": "Janet", 
            "id": "sg:person.01020040343.98", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020040343.98"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Section of Paediatrics, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Section of Paediatrics, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hargrave", 
            "givenName": "Darren", 
            "id": "sg:person.0605152436.01", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0605152436.01"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Section of Paediatrics, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Section of Paediatrics, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Pritchard-Jones", 
            "givenName": "Katherine", 
            "id": "sg:person.01263340623.74", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01263340623.74"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biology, YCR Cancer Research Unit, University of York, YO10 5YW, York, UK", 
              "id": "http://www.grid.ac/institutes/grid.5685.e", 
              "name": [
                "Department of Biology, YCR Cancer Research Unit, University of York, YO10 5YW, York, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Maitland", 
            "givenName": "Norman", 
            "id": "sg:person.01201421136.25", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201421136.25"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Queensland Institute of Medical Research, RBH Post Office Herston, 4029, Queensland, Australia", 
              "id": "http://www.grid.ac/institutes/grid.1049.c", 
              "name": [
                "Queensland Institute of Medical Research, RBH Post Office Herston, 4029, Queensland, Australia"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chenevix-Trench", 
            "givenName": "Georgia", 
            "id": "sg:person.01012310162.58", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012310162.58"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pathology, Duke University Medical Centre, 27710, Durham, North Carolina, USA", 
              "id": "http://www.grid.ac/institutes/grid.414179.e", 
              "name": [
                "Department of Pathology, Duke University Medical Centre, 27710, Durham, North Carolina, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Riggins", 
            "givenName": "Gregory J.", 
            "id": "sg:person.011127424477.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011127424477.35"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pathology, Duke University Medical Centre, 27710, Durham, North Carolina, USA", 
              "id": "http://www.grid.ac/institutes/grid.414179.e", 
              "name": [
                "Department of Pathology, Duke University Medical Centre, 27710, Durham, North Carolina, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bigner", 
            "givenName": "Darell D.", 
            "id": "sg:person.013515206217.45", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013515206217.45"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institute of Molecular Genetics, C.N.R, Loc. Tramariglio, 07040, Alghero, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Institute of Molecular Genetics, C.N.R, Loc. Tramariglio, 07040, Alghero, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Palmieri", 
            "givenName": "Giuseppe", 
            "id": "sg:person.0762206722.62", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762206722.62"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pathology, University of Sassari, Azienda USL1, 07100, Sassari, Italy", 
              "id": "http://www.grid.ac/institutes/grid.11450.31", 
              "name": [
                "Department of Pathology, University of Sassari, Azienda USL1, 07100, Sassari, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cossu", 
            "givenName": "Antonio", 
            "id": "sg:person.01362655536.95", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362655536.95"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Duke University Medical Centre, 27710, Durham, North Carolina, USA", 
              "id": "http://www.grid.ac/institutes/grid.414179.e", 
              "name": [
                "Royal Free & University College Medical School, WC1E 6JJ, London, UK", 
                "Department of Surgery, Duke University Medical Centre, 27710, Durham, North Carolina, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Flanagan", 
            "givenName": "Adrienne", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Royal Brompton Hospital, SW3 6NP, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.439338.6", 
              "name": [
                "Royal Brompton Hospital, SW3 6NP, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nicholson", 
            "givenName": "Andrew", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong", 
              "id": "http://www.grid.ac/institutes/grid.415550.0", 
              "name": [
                "Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ho", 
            "givenName": "Judy W. C.", 
            "id": "sg:person.012766162222.96", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012766162222.96"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Hong Kong", 
              "id": "http://www.grid.ac/institutes/grid.415550.0", 
              "name": [
                "Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Hong Kong"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Leung", 
            "givenName": "Suet Y.", 
            "id": "sg:person.01001026775.03", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001026775.03"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Hong Kong", 
              "id": "http://www.grid.ac/institutes/grid.415550.0", 
              "name": [
                "Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Hong Kong"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yuen", 
            "givenName": "Siu T.", 
            "id": "sg:person.015056360341.89", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015056360341.89"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Abramson Family Cancer Research Institute, University of Pennsylvania Cancer Center, 19104, Philadelphia, Pennsylvania, USA", 
              "id": "http://www.grid.ac/institutes/grid.516138.8", 
              "name": [
                "Abramson Family Cancer Research Institute, University of Pennsylvania Cancer Center, 19104, Philadelphia, Pennsylvania, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Weber", 
            "givenName": "Barbara L.", 
            "id": "sg:person.013374743752.41", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013374743752.41"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Duke University Medical Centre, 27710, Durham, North Carolina, USA", 
              "id": "http://www.grid.ac/institutes/grid.414179.e", 
              "name": [
                "Department of Surgery, Duke University Medical Centre, 27710, Durham, North Carolina, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Seigler", 
            "givenName": "Hilliard F.", 
            "id": "sg:person.01171033426.18", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171033426.18"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Duke University Medical Centre, 27710, Durham, North Carolina, USA", 
              "id": "http://www.grid.ac/institutes/grid.414179.e", 
              "name": [
                "Department of Surgery, Duke University Medical Centre, 27710, Durham, North Carolina, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Darrow", 
            "givenName": "Timothy L.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Research UK Centre for Cell and Molecular Biology, Chester Beatty Labs, Institute of Cancer Research, SW3 6JB, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Cancer Research UK Centre for Cell and Molecular Biology, Chester Beatty Labs, Institute of Cancer Research, SW3 6JB, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Paterson", 
            "givenName": "Hugh", 
            "id": "sg:person.01331730056.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331730056.14"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Research UK Centre for Cell and Molecular Biology, Chester Beatty Labs, Institute of Cancer Research, SW3 6JB, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Cancer Research UK Centre for Cell and Molecular Biology, Chester Beatty Labs, Institute of Cancer Research, SW3 6JB, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Marais", 
            "givenName": "Richard", 
            "id": "sg:person.01350442021.64", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01350442021.64"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Research UK Centre for Cell and Molecular Biology, Chester Beatty Labs, Institute of Cancer Research, SW3 6JB, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Cancer Research UK Centre for Cell and Molecular Biology, Chester Beatty Labs, Institute of Cancer Research, SW3 6JB, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Marshall", 
            "givenName": "Christopher J.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Section of Molecular Carcinogenesis, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
                "Section of Molecular Carcinogenesis, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wooster", 
            "givenName": "Richard", 
            "id": "sg:person.01322231014.50", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322231014.50"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Section of Cancer Genetics, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
                "Section of Cancer Genetics, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Stratton", 
            "givenName": "Michael R.", 
            "id": "sg:person.010101505177.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010101505177.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Futreal", 
            "givenName": "P. Andrew", 
            "id": "sg:person.0653224107.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653224107.08"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/313241a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052282285", 
              "https://doi.org/10.1038/313241a0"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2002-06-09", 
        "datePublishedReg": "2002-06-09", 
        "description": "Cancers arise owing to the accumulation of mutations in critical genes that alter normal programmes of cell proliferation, differentiation and death. As the first stage of a systematic genome-wide screen for these genes, we have prioritized for analysis signalling pathways in which at least one gene is mutated in human cancer. The RAS\u2013RAF\u2013MEK\u2013ERK\u2013MAP kinase pathway mediates cellular responses to growth signals1. RAS is mutated to an oncogenic form in about 15% of human cancer. The three RAF genes code for cytoplasmic serine/threonine kinases that are regulated by binding RAS1,2,3. Here we report BRAF somatic missense mutations in 66% of malignant melanomas and at lower frequency in a wide range of human cancers. All mutations are within the kinase domain, with a single substitution (V599E) accounting for 80%. Mutated BRAF proteins have elevated kinase activity and are transforming in NIH3T3 cells. Furthermore, RAS function is not required for the growth of cancer cell lines with the V599E mutation. As BRAF is a serine/threonine kinase that is commonly activated by somatic point mutation in human cancer, it may provide new therapeutic opportunities in malignant melanoma.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/nature00766", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.8483042", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.7580433", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0028-0836", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "6892", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "417"
          }
        ], 
        "keywords": [
          "serine/threonine kinase", 
          "human cancers", 
          "threonine kinase", 
          "cytoplasmic serine/threonine kinase", 
          "systematic genome-wide screens", 
          "genome-wide screen", 
          "MAP kinase pathway", 
          "accumulation of mutations", 
          "somatic missense mutations", 
          "gene codes", 
          "kinase domain", 
          "oncogenic forms", 
          "RAS function", 
          "critical genes", 
          "kinase pathway", 
          "kinase activity", 
          "NIH3T3 cells", 
          "new therapeutic opportunities", 
          "somatic point mutations", 
          "MEK-ERK", 
          "cellular responses", 
          "RAS-RAF", 
          "genes", 
          "point mutations", 
          "single substitution", 
          "cancer cell lines", 
          "missense mutations", 
          "mutations", 
          "BRAF protein", 
          "cell proliferation", 
          "cell lines", 
          "V599E mutation", 
          "kinase", 
          "therapeutic opportunities", 
          "pathway", 
          "BRAF gene", 
          "normal programs", 
          "protein", 
          "differentiation", 
          "proliferation", 
          "cancer", 
          "RAS", 
          "cells", 
          "accumulation", 
          "screen", 
          "domain", 
          "wide range", 
          "growth", 
          "BRAF", 
          "substitution", 
          "lines", 
          "activity", 
          "melanoma", 
          "malignant melanoma", 
          "function", 
          "response", 
          "stage", 
          "death", 
          "low frequency", 
          "analysis", 
          "form", 
          "range", 
          "opportunities", 
          "frequency", 
          "first stage", 
          "program", 
          "code"
        ], 
        "name": "Mutations of the BRAF gene in human cancer", 
        "pagination": "949-954", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1023536940"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/nature00766"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "12068308"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/nature00766", 
          "https://app.dimensions.ai/details/publication/pub.1023536940"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-12-01T06:23", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_345.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/nature00766"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nature00766'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nature00766'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nature00766'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nature00766'


     

    This table displays all metadata directly associated to this object as RDF triples.

    609 TRIPLES      21 PREDICATES      117 URIs      105 LITERALS      28 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/nature00766 schema:about N05182ee1827147468a906dd2348bd7ae
    2 N150a1c8d9aee40a28fb64ff5b7701966
    3 N1b6ece5b1f324c4b868a3ad25ead40f7
    4 N1c3e7b1e6c6d4caab092d8ce2990b7ba
    5 N1cc872e01cf540e1b338ed08d58ab8b2
    6 N4663221fa4294b7bade8f9d95bbec177
    7 N48c7463af5c949a998c3d7708d15dfdb
    8 N5525d191e5844e5a80296d8b91af3e30
    9 N55a94d7596e34654ac56ff65060ffb27
    10 N5f1d5d07ce3b4b2482ad7c6219da0df1
    11 N69552c48a29240f5ac1b974923f95378
    12 N83f4d3a24b6845ae8a9f137e33d2ab77
    13 N93eef88cdf02435f94b4d1ee489dcade
    14 N968f9a314cfc4f77a3ca18257aa71314
    15 N9aaa81cace6044dc9326924171d8e8c4
    16 Nb507de73c06b4c458878441bbc4d67d4
    17 Nd453b91043954ff19316a461d4ce4b22
    18 Ne82d310da24c42608ee603d582fb6d7d
    19 Nf6d40442342a4b0ea9b43e0d797808cf
    20 Nfe18c1db8d0f4e9491ec407f3e505798
    21 Nff5bc1174485441c97efed8278a8d8bc
    22 anzsrc-for:06
    23 anzsrc-for:0601
    24 anzsrc-for:0604
    25 anzsrc-for:11
    26 anzsrc-for:1112
    27 schema:author Nddd97962767348bb80a5d888090f18da
    28 schema:citation sg:pub.10.1038/313241a0
    29 schema:datePublished 2002-06-09
    30 schema:datePublishedReg 2002-06-09
    31 schema:description Cancers arise owing to the accumulation of mutations in critical genes that alter normal programmes of cell proliferation, differentiation and death. As the first stage of a systematic genome-wide screen for these genes, we have prioritized for analysis signalling pathways in which at least one gene is mutated in human cancer. The RAS–RAF–MEK–ERK–MAP kinase pathway mediates cellular responses to growth signals1. RAS is mutated to an oncogenic form in about 15% of human cancer. The three RAF genes code for cytoplasmic serine/threonine kinases that are regulated by binding RAS1,2,3. Here we report BRAF somatic missense mutations in 66% of malignant melanomas and at lower frequency in a wide range of human cancers. All mutations are within the kinase domain, with a single substitution (V599E) accounting for 80%. Mutated BRAF proteins have elevated kinase activity and are transforming in NIH3T3 cells. Furthermore, RAS function is not required for the growth of cancer cell lines with the V599E mutation. As BRAF is a serine/threonine kinase that is commonly activated by somatic point mutation in human cancer, it may provide new therapeutic opportunities in malignant melanoma.
    32 schema:genre article
    33 schema:isAccessibleForFree true
    34 schema:isPartOf N9b56a4fc30a8462c8ef8f15fe48471c9
    35 Nd11bba6c49ab4749af7bb72cef5bf73e
    36 sg:journal.1018957
    37 schema:keywords BRAF
    38 BRAF gene
    39 BRAF protein
    40 MAP kinase pathway
    41 MEK-ERK
    42 NIH3T3 cells
    43 RAS
    44 RAS function
    45 RAS-RAF
    46 V599E mutation
    47 accumulation
    48 accumulation of mutations
    49 activity
    50 analysis
    51 cancer
    52 cancer cell lines
    53 cell lines
    54 cell proliferation
    55 cells
    56 cellular responses
    57 code
    58 critical genes
    59 cytoplasmic serine/threonine kinase
    60 death
    61 differentiation
    62 domain
    63 first stage
    64 form
    65 frequency
    66 function
    67 gene codes
    68 genes
    69 genome-wide screen
    70 growth
    71 human cancers
    72 kinase
    73 kinase activity
    74 kinase domain
    75 kinase pathway
    76 lines
    77 low frequency
    78 malignant melanoma
    79 melanoma
    80 missense mutations
    81 mutations
    82 new therapeutic opportunities
    83 normal programs
    84 oncogenic forms
    85 opportunities
    86 pathway
    87 point mutations
    88 program
    89 proliferation
    90 protein
    91 range
    92 response
    93 screen
    94 serine/threonine kinase
    95 single substitution
    96 somatic missense mutations
    97 somatic point mutations
    98 stage
    99 substitution
    100 systematic genome-wide screens
    101 therapeutic opportunities
    102 threonine kinase
    103 wide range
    104 schema:name Mutations of the BRAF gene in human cancer
    105 schema:pagination 949-954
    106 schema:productId N5a8132f5c2774448a9e12b0562380d7a
    107 N720c17e403f9413d8d43009ced81f083
    108 Na964b714d76e466db9bcca59ef34735f
    109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023536940
    110 https://doi.org/10.1038/nature00766
    111 schema:sdDatePublished 2022-12-01T06:23
    112 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    113 schema:sdPublisher N11d1cd7e11bb495ca2dfc212abb61124
    114 schema:url https://doi.org/10.1038/nature00766
    115 sgo:license sg:explorer/license/
    116 sgo:sdDataset articles
    117 rdf:type schema:ScholarlyArticle
    118 N00eb96c241a64b05b7bde3b73a8a0e6d rdf:first sg:person.01350442021.64
    119 rdf:rest N5d7cda4f81694a1d8bb043127f279854
    120 N049c0bb6241441b8b5fce08f1f247b2e rdf:first N1878323ad193469baa7df5ee81953624
    121 rdf:rest Ne79945370a574ecf937018e4b9d885eb
    122 N05182ee1827147468a906dd2348bd7ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name Molecular Sequence Data
    124 rdf:type schema:DefinedTerm
    125 N09386fe4054148968ec09a47fd8da5f4 rdf:first sg:person.0762206722.62
    126 rdf:rest Ne15c07742333493aaf2c171dce183271
    127 N0a9ec865f656497790c6251f02ebc62b rdf:first sg:person.0641077014.15
    128 rdf:rest N3aa550e14bcf4afd885b18d937e2377b
    129 N11d1cd7e11bb495ca2dfc212abb61124 schema:name Springer Nature - SN SciGraph project
    130 rdf:type schema:Organization
    131 N150a1c8d9aee40a28fb64ff5b7701966 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Mice
    133 rdf:type schema:DefinedTerm
    134 N15a88edd176540fb9925604f0218ab99 rdf:first sg:person.01263340623.74
    135 rdf:rest N36b011b5c7bf49df8d7477b40b434308
    136 N1878323ad193469baa7df5ee81953624 schema:affiliation grid-institutes:grid.18886.3f
    137 schema:familyName Hooper
    138 schema:givenName Steven
    139 rdf:type schema:Person
    140 N18e936aece2b4279b9369b25f02f65fe rdf:first sg:person.01156170354.76
    141 rdf:rest Ncadee9067988400bb917ef9d3308955d
    142 N1ac81fdaabfc427f98c3fda083a16ff1 rdf:first sg:person.0653604740.05
    143 rdf:rest N76db497ffb7044c4abef6b48dda1c66f
    144 N1b6ece5b1f324c4b868a3ad25ead40f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name DNA Mutational Analysis
    146 rdf:type schema:DefinedTerm
    147 N1c3e7b1e6c6d4caab092d8ce2990b7ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    148 schema:name Amino Acid Sequence
    149 rdf:type schema:DefinedTerm
    150 N1cc872e01cf540e1b338ed08d58ab8b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Proto-Oncogene Proteins B-raf
    152 rdf:type schema:DefinedTerm
    153 N1f75a046bd9143f5852aaf46b0ff71ac rdf:first sg:person.0677171015.08
    154 rdf:rest N7b7ba6c8ea15463e995834311d19a375
    155 N292d55a95f4e4063a6ab4ba57bd2b6d0 rdf:first N38dfd0e7e72044518abbda24a7e50170
    156 rdf:rest N6b62b49dcd4e44afa920bccb6591e775
    157 N2ad9beff71024a71ae12baa43277bc6f rdf:first sg:person.01032251502.18
    158 rdf:rest N1f75a046bd9143f5852aaf46b0ff71ac
    159 N2b1aff8a74bc4e859cdbbd8a13cd9723 rdf:first sg:person.01322231014.50
    160 rdf:rest Ncaae739a95714335a4f2de3e7bb33875
    161 N35be22c7978746e987c6d06eae3bd830 schema:affiliation grid-institutes:None
    162 schema:familyName Ewing
    163 schema:givenName Rebecca
    164 rdf:type schema:Person
    165 N36b011b5c7bf49df8d7477b40b434308 rdf:first sg:person.01201421136.25
    166 rdf:rest Nb59a385284e64c1d8f4e10f02df641e0
    167 N38dfd0e7e72044518abbda24a7e50170 schema:affiliation grid-institutes:None
    168 schema:familyName Mould
    169 schema:givenName Catherine
    170 rdf:type schema:Person
    171 N3aa550e14bcf4afd885b18d937e2377b rdf:first Ne13845e3372744fe98042b3c5aaaa366
    172 rdf:rest N67480251ac6044bd9879a1de23b90051
    173 N439ec1547262467f8b7f9db6a154e1b9 schema:affiliation grid-institutes:None
    174 schema:familyName Teague
    175 schema:givenName Jon
    176 rdf:type schema:Person
    177 N455c275f35484653adc724c757313c05 schema:affiliation grid-institutes:grid.439338.6
    178 schema:familyName Nicholson
    179 schema:givenName Andrew
    180 rdf:type schema:Person
    181 N4663221fa4294b7bade8f9d95bbec177 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    182 schema:name Tumor Cells, Cultured
    183 rdf:type schema:DefinedTerm
    184 N48c7463af5c949a998c3d7708d15dfdb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    185 schema:name MAP Kinase Signaling System
    186 rdf:type schema:DefinedTerm
    187 N49172ad6b51f4404aa5e86e4b1d3dbff rdf:first N4d179620b09545169d3efc72cbf98ef4
    188 rdf:rest N9850015a551c46599fc390ec36a38cd0
    189 N4b0cd05b4047439a9f640eaf2e9ab116 schema:affiliation grid-institutes:None
    190 schema:familyName Parker
    191 schema:givenName Adrian
    192 rdf:type schema:Person
    193 N4d179620b09545169d3efc72cbf98ef4 schema:affiliation grid-institutes:grid.414179.e
    194 schema:familyName Darrow
    195 schema:givenName Timothy L.
    196 rdf:type schema:Person
    197 N4e1986ad3f824e61ba56a15893a2f0c7 rdf:first sg:person.01171033426.18
    198 rdf:rest N49172ad6b51f4404aa5e86e4b1d3dbff
    199 N517dbfdf4bcf480dbe78cb9f4e0c05db rdf:first sg:person.0666455053.98
    200 rdf:rest Nd4de58e1101645708132eb5e892077c5
    201 N5525d191e5844e5a80296d8b91af3e30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    202 schema:name Cell Division
    203 rdf:type schema:DefinedTerm
    204 N55a94d7596e34654ac56ff65060ffb27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    205 schema:name Cell Transformation, Neoplastic
    206 rdf:type schema:DefinedTerm
    207 N5a8132f5c2774448a9e12b0562380d7a schema:name dimensions_id
    208 schema:value pub.1023536940
    209 rdf:type schema:PropertyValue
    210 N5c0fe8bfe7a8481e8e991106eba215dc rdf:first sg:person.01020040343.98
    211 rdf:rest Ne72cc1899fc849e5b4b40d584dab5345
    212 N5d7cda4f81694a1d8bb043127f279854 rdf:first N697f65bf6bc442879f02c0e6016b1f5f
    213 rdf:rest N2b1aff8a74bc4e859cdbbd8a13cd9723
    214 N5f1d5d07ce3b4b2482ad7c6219da0df1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    215 schema:name Melanoma
    216 rdf:type schema:DefinedTerm
    217 N62afed9d7c7046398ae2e3c55039bc59 schema:affiliation grid-institutes:None
    218 schema:familyName Clegg
    219 schema:givenName Sheila
    220 rdf:type schema:Person
    221 N635d86385783439eaeefedebfecd2040 schema:affiliation grid-institutes:None
    222 schema:familyName Davis
    223 schema:givenName Neil
    224 rdf:type schema:Person
    225 N67480251ac6044bd9879a1de23b90051 rdf:first Ncdffec62827b4241856c42aa10a748e8
    226 rdf:rest N92d93e4ebc6e4dc983791f3971769c4e
    227 N69552c48a29240f5ac1b974923f95378 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    228 schema:name Humans
    229 rdf:type schema:DefinedTerm
    230 N697f65bf6bc442879f02c0e6016b1f5f schema:affiliation grid-institutes:grid.18886.3f
    231 schema:familyName Marshall
    232 schema:givenName Christopher J.
    233 rdf:type schema:Person
    234 N69bdaf175d404640893f9e8c8b8a7c5e schema:affiliation grid-institutes:None
    235 schema:familyName Hawes
    236 schema:givenName Rachel
    237 rdf:type schema:Person
    238 N6b62b49dcd4e44afa920bccb6591e775 rdf:first N4b0cd05b4047439a9f640eaf2e9ab116
    239 rdf:rest Nbb2be8a5cef64e489013bb3bc099f8e6
    240 N720c17e403f9413d8d43009ced81f083 schema:name pubmed_id
    241 schema:value 12068308
    242 rdf:type schema:PropertyValue
    243 N732f282abe4b40db8e4da1ea6ea814ee schema:affiliation grid-institutes:None
    244 schema:familyName Watt
    245 schema:givenName Stephen
    246 rdf:type schema:Person
    247 N76db497ffb7044c4abef6b48dda1c66f rdf:first N635d86385783439eaeefedebfecd2040
    248 rdf:rest Nbaba3b9585ad451e8b66f3c7836082fb
    249 N7b7ba6c8ea15463e995834311d19a375 rdf:first sg:person.0775127652.18
    250 rdf:rest N5c0fe8bfe7a8481e8e991106eba215dc
    251 N7ce597d171a74a718a11a0a2379b4da7 rdf:first sg:person.01340070130.03
    252 rdf:rest N88330b71e543455db2440abf8b595e3f
    253 N7f4238ffa218407b96ad3dc824dc3947 schema:affiliation grid-institutes:grid.18886.3f
    254 schema:familyName Wilson
    255 schema:givenName Rebecca
    256 rdf:type schema:Person
    257 N83f4d3a24b6845ae8a9f137e33d2ab77 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    258 schema:name ras Proteins
    259 rdf:type schema:DefinedTerm
    260 N88330b71e543455db2440abf8b595e3f rdf:first sg:person.01110741774.63
    261 rdf:rest N1ac81fdaabfc427f98c3fda083a16ff1
    262 N8fd0fa2ece6d4155bb1a9268d30f24be rdf:first sg:person.011127424477.35
    263 rdf:rest Nb3583e0bac1946559b2345a5f68b9ad5
    264 N9011964213d94ec7b64947edcec5b65e schema:affiliation grid-institutes:None
    265 schema:familyName Menzies
    266 schema:givenName Andrew
    267 rdf:type schema:Person
    268 N92d93e4ebc6e4dc983791f3971769c4e rdf:first sg:person.0744515657.65
    269 rdf:rest Ndc88d4d2eecc4c82bf3e4eb910e1a87d
    270 N93eef88cdf02435f94b4d1ee489dcade schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    271 schema:name Proto-Oncogene Proteins c-raf
    272 rdf:type schema:DefinedTerm
    273 N9458214a06f442ce9206f0d5629fc0f1 rdf:first sg:person.0744552267.05
    274 rdf:rest N18e936aece2b4279b9369b25f02f65fe
    275 N968f9a314cfc4f77a3ca18257aa71314 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    276 schema:name 3T3 Cells
    277 rdf:type schema:DefinedTerm
    278 N9850015a551c46599fc390ec36a38cd0 rdf:first sg:person.01331730056.14
    279 rdf:rest N00eb96c241a64b05b7bde3b73a8a0e6d
    280 N9aaa81cace6044dc9326924171d8e8c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    281 schema:name Base Sequence
    282 rdf:type schema:DefinedTerm
    283 N9b56a4fc30a8462c8ef8f15fe48471c9 schema:volumeNumber 417
    284 rdf:type schema:PublicationVolume
    285 N9f618d1829d84a34b0b4e34e5ceb283a rdf:first Ndc7feb397b2340069596bc0f1a611adf
    286 rdf:rest N517dbfdf4bcf480dbe78cb9f4e0c05db
    287 Na964b714d76e466db9bcca59ef34735f schema:name doi
    288 schema:value 10.1038/nature00766
    289 rdf:type schema:PropertyValue
    290 Nad6bf68fd08a48c6bfc999424306fdcf schema:affiliation grid-institutes:None
    291 schema:familyName Hall
    292 schema:givenName Sarah
    293 rdf:type schema:Person
    294 Nadd2cc292b2c42c48041f4b2535a2409 rdf:first N35be22c7978746e987c6d06eae3bd830
    295 rdf:rest N9f618d1829d84a34b0b4e34e5ceb283a
    296 Nb3583e0bac1946559b2345a5f68b9ad5 rdf:first sg:person.013515206217.45
    297 rdf:rest N09386fe4054148968ec09a47fd8da5f4
    298 Nb507de73c06b4c458878441bbc4d67d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    299 schema:name Protein Structure, Tertiary
    300 rdf:type schema:DefinedTerm
    301 Nb59a385284e64c1d8f4e10f02df641e0 rdf:first sg:person.01012310162.58
    302 rdf:rest N8fd0fa2ece6d4155bb1a9268d30f24be
    303 Nb5d97061d8cd426bb3fb902f6475134d rdf:first sg:person.013374743752.41
    304 rdf:rest N4e1986ad3f824e61ba56a15893a2f0c7
    305 Nb61c5785f5bb40b8ac57734b1646e13e rdf:first sg:person.012766162222.96
    306 rdf:rest Ncce1d6ca0e4f4235aacf8f5e4eb6f96c
    307 Nbaba3b9585ad451e8b66f3c7836082fb rdf:first sg:person.01235133752.67
    308 rdf:rest Nadd2cc292b2c42c48041f4b2535a2409
    309 Nbb2be8a5cef64e489013bb3bc099f8e6 rdf:first Neacbd1a3b7b444e69e9683ed86fa2e3c
    310 rdf:rest Nf05a93d35bba42a1869e2d7bb90cbe99
    311 Nbc7d10536fdb460ea2137d8f72db76f9 rdf:first N439ec1547262467f8b7f9db6a154e1b9
    312 rdf:rest N7ce597d171a74a718a11a0a2379b4da7
    313 Nc39439c7e95048a78a46feea6e893426 rdf:first Ndeba829fb3ad4bf0b85af285e7c002e7
    314 rdf:rest Nf381c6a1c749439fbb02e3907d8467b0
    315 Nc4a04fc836594291a353c6cf3fd605ae rdf:first sg:person.015056360341.89
    316 rdf:rest Nb5d97061d8cd426bb3fb902f6475134d
    317 Ncaae739a95714335a4f2de3e7bb33875 rdf:first sg:person.010101505177.49
    318 rdf:rest Ne806acdfe98d48cd8122f6f51ca88983
    319 Ncadee9067988400bb917ef9d3308955d rdf:first N9011964213d94ec7b64947edcec5b65e
    320 rdf:rest N292d55a95f4e4063a6ab4ba57bd2b6d0
    321 Ncce1d6ca0e4f4235aacf8f5e4eb6f96c rdf:first sg:person.01001026775.03
    322 rdf:rest Nc4a04fc836594291a353c6cf3fd605ae
    323 Ncdffec62827b4241856c42aa10a748e8 schema:affiliation grid-institutes:None
    324 schema:familyName Stephens
    325 schema:givenName Philip
    326 rdf:type schema:Person
    327 Nd11bba6c49ab4749af7bb72cef5bf73e schema:issueNumber 6892
    328 rdf:type schema:PublicationIssue
    329 Nd453b91043954ff19316a461d4ce4b22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    330 schema:name Enzyme Activation
    331 rdf:type schema:DefinedTerm
    332 Nd4de58e1101645708132eb5e892077c5 rdf:first Nad6bf68fd08a48c6bfc999424306fdcf
    333 rdf:rest Nf898393d756b43a7ae985b0cc985c4a3
    334 Ndc7feb397b2340069596bc0f1a611adf schema:affiliation grid-institutes:None
    335 schema:familyName Floyd
    336 schema:givenName Yvonne
    337 rdf:type schema:Person
    338 Ndc88d4d2eecc4c82bf3e4eb910e1a87d rdf:first N62afed9d7c7046398ae2e3c55039bc59
    339 rdf:rest Nbc7d10536fdb460ea2137d8f72db76f9
    340 Ndd4c9841c6e74800aab68a52c853a1b3 schema:affiliation grid-institutes:None
    341 schema:familyName Davies
    342 schema:givenName Helen
    343 rdf:type schema:Person
    344 Nddd97962767348bb80a5d888090f18da rdf:first Ndd4c9841c6e74800aab68a52c853a1b3
    345 rdf:rest N0a9ec865f656497790c6251f02ebc62b
    346 Ndeba829fb3ad4bf0b85af285e7c002e7 schema:affiliation grid-institutes:grid.414179.e
    347 schema:familyName Flanagan
    348 schema:givenName Adrienne
    349 rdf:type schema:Person
    350 Ne13845e3372744fe98042b3c5aaaa366 schema:affiliation grid-institutes:None
    351 schema:familyName Cox
    352 schema:givenName Charles
    353 rdf:type schema:Person
    354 Ne15c07742333493aaf2c171dce183271 rdf:first sg:person.01362655536.95
    355 rdf:rest Nc39439c7e95048a78a46feea6e893426
    356 Ne72cc1899fc849e5b4b40d584dab5345 rdf:first sg:person.0605152436.01
    357 rdf:rest N15a88edd176540fb9925604f0218ab99
    358 Ne79945370a574ecf937018e4b9d885eb rdf:first N7f4238ffa218407b96ad3dc824dc3947
    359 rdf:rest N2ad9beff71024a71ae12baa43277bc6f
    360 Ne806acdfe98d48cd8122f6f51ca88983 rdf:first sg:person.0653224107.08
    361 rdf:rest rdf:nil
    362 Ne82d310da24c42608ee603d582fb6d7d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    363 schema:name Neoplasms
    364 rdf:type schema:DefinedTerm
    365 Neacbd1a3b7b444e69e9683ed86fa2e3c schema:affiliation grid-institutes:None
    366 schema:familyName Stevens
    367 schema:givenName Claire
    368 rdf:type schema:Person
    369 Nf05a93d35bba42a1869e2d7bb90cbe99 rdf:first N732f282abe4b40db8e4da1ea6ea814ee
    370 rdf:rest N049c0bb6241441b8b5fce08f1f247b2e
    371 Nf381c6a1c749439fbb02e3907d8467b0 rdf:first N455c275f35484653adc724c757313c05
    372 rdf:rest Nb61c5785f5bb40b8ac57734b1646e13e
    373 Nf6d40442342a4b0ea9b43e0d797808cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    374 schema:name Animals
    375 rdf:type schema:DefinedTerm
    376 Nf898393d756b43a7ae985b0cc985c4a3 rdf:first N69bdaf175d404640893f9e8c8b8a7c5e
    377 rdf:rest N9458214a06f442ce9206f0d5629fc0f1
    378 Nfe18c1db8d0f4e9491ec407f3e505798 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    379 schema:name Mitogen-Activated Protein Kinases
    380 rdf:type schema:DefinedTerm
    381 Nff5bc1174485441c97efed8278a8d8bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    382 schema:name Mutation, Missense
    383 rdf:type schema:DefinedTerm
    384 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    385 schema:name Biological Sciences
    386 rdf:type schema:DefinedTerm
    387 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
    388 schema:name Biochemistry and Cell Biology
    389 rdf:type schema:DefinedTerm
    390 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
    391 schema:name Genetics
    392 rdf:type schema:DefinedTerm
    393 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    394 schema:name Medical and Health Sciences
    395 rdf:type schema:DefinedTerm
    396 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    397 schema:name Oncology and Carcinogenesis
    398 rdf:type schema:DefinedTerm
    399 sg:grant.7580433 http://pending.schema.org/fundedItem sg:pub.10.1038/nature00766
    400 rdf:type schema:MonetaryGrant
    401 sg:grant.8483042 http://pending.schema.org/fundedItem sg:pub.10.1038/nature00766
    402 rdf:type schema:MonetaryGrant
    403 sg:journal.1018957 schema:issn 0028-0836
    404 1476-4687
    405 schema:name Nature
    406 schema:publisher Springer Nature
    407 rdf:type schema:Periodical
    408 sg:person.01001026775.03 schema:affiliation grid-institutes:grid.415550.0
    409 schema:familyName Leung
    410 schema:givenName Suet Y.
    411 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001026775.03
    412 rdf:type schema:Person
    413 sg:person.010101505177.49 schema:affiliation grid-institutes:grid.18886.3f
    414 schema:familyName Stratton
    415 schema:givenName Michael R.
    416 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010101505177.49
    417 rdf:type schema:Person
    418 sg:person.01012310162.58 schema:affiliation grid-institutes:grid.1049.c
    419 schema:familyName Chenevix-Trench
    420 schema:givenName Georgia
    421 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012310162.58
    422 rdf:type schema:Person
    423 sg:person.01020040343.98 schema:affiliation grid-institutes:grid.18886.3f
    424 schema:familyName Shipley
    425 schema:givenName Janet
    426 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020040343.98
    427 rdf:type schema:Person
    428 sg:person.01032251502.18 schema:affiliation grid-institutes:grid.18886.3f
    429 schema:familyName Jayatilake
    430 schema:givenName Hiran
    431 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032251502.18
    432 rdf:type schema:Person
    433 sg:person.01110741774.63 schema:affiliation grid-institutes:grid.18886.3f
    434 schema:familyName Garnett
    435 schema:givenName Mathew J.
    436 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110741774.63
    437 rdf:type schema:Person
    438 sg:person.011127424477.35 schema:affiliation grid-institutes:grid.414179.e
    439 schema:familyName Riggins
    440 schema:givenName Gregory J.
    441 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011127424477.35
    442 rdf:type schema:Person
    443 sg:person.01156170354.76 schema:affiliation grid-institutes:None
    444 schema:familyName Kosmidou
    445 schema:givenName Vivian
    446 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156170354.76
    447 rdf:type schema:Person
    448 sg:person.01171033426.18 schema:affiliation grid-institutes:grid.414179.e
    449 schema:familyName Seigler
    450 schema:givenName Hilliard F.
    451 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171033426.18
    452 rdf:type schema:Person
    453 sg:person.01201421136.25 schema:affiliation grid-institutes:grid.5685.e
    454 schema:familyName Maitland
    455 schema:givenName Norman
    456 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201421136.25
    457 rdf:type schema:Person
    458 sg:person.01235133752.67 schema:affiliation grid-institutes:None
    459 schema:familyName Dicks
    460 schema:givenName Ed
    461 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235133752.67
    462 rdf:type schema:Person
    463 sg:person.01263340623.74 schema:affiliation grid-institutes:grid.18886.3f
    464 schema:familyName Pritchard-Jones
    465 schema:givenName Katherine
    466 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01263340623.74
    467 rdf:type schema:Person
    468 sg:person.012766162222.96 schema:affiliation grid-institutes:grid.415550.0
    469 schema:familyName Ho
    470 schema:givenName Judy W. C.
    471 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012766162222.96
    472 rdf:type schema:Person
    473 sg:person.01322231014.50 schema:affiliation grid-institutes:grid.18886.3f
    474 schema:familyName Wooster
    475 schema:givenName Richard
    476 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322231014.50
    477 rdf:type schema:Person
    478 sg:person.01331730056.14 schema:affiliation grid-institutes:grid.18886.3f
    479 schema:familyName Paterson
    480 schema:givenName Hugh
    481 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331730056.14
    482 rdf:type schema:Person
    483 sg:person.013374743752.41 schema:affiliation grid-institutes:grid.516138.8
    484 schema:familyName Weber
    485 schema:givenName Barbara L.
    486 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013374743752.41
    487 rdf:type schema:Person
    488 sg:person.01340070130.03 schema:affiliation grid-institutes:None
    489 schema:familyName Woffendin
    490 schema:givenName Hayley
    491 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340070130.03
    492 rdf:type schema:Person
    493 sg:person.01350442021.64 schema:affiliation grid-institutes:grid.18886.3f
    494 schema:familyName Marais
    495 schema:givenName Richard
    496 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01350442021.64
    497 rdf:type schema:Person
    498 sg:person.013515206217.45 schema:affiliation grid-institutes:grid.414179.e
    499 schema:familyName Bigner
    500 schema:givenName Darell D.
    501 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013515206217.45
    502 rdf:type schema:Person
    503 sg:person.01362655536.95 schema:affiliation grid-institutes:grid.11450.31
    504 schema:familyName Cossu
    505 schema:givenName Antonio
    506 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362655536.95
    507 rdf:type schema:Person
    508 sg:person.015056360341.89 schema:affiliation grid-institutes:grid.415550.0
    509 schema:familyName Yuen
    510 schema:givenName Siu T.
    511 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015056360341.89
    512 rdf:type schema:Person
    513 sg:person.0605152436.01 schema:affiliation grid-institutes:grid.18886.3f
    514 schema:familyName Hargrave
    515 schema:givenName Darren
    516 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0605152436.01
    517 rdf:type schema:Person
    518 sg:person.0641077014.15 schema:affiliation grid-institutes:None
    519 schema:familyName Bignell
    520 schema:givenName Graham R.
    521 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641077014.15
    522 rdf:type schema:Person
    523 sg:person.0653224107.08 schema:affiliation grid-institutes:None
    524 schema:familyName Futreal
    525 schema:givenName P. Andrew
    526 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653224107.08
    527 rdf:type schema:Person
    528 sg:person.0653604740.05 schema:affiliation grid-institutes:None
    529 schema:familyName Bottomley
    530 schema:givenName William
    531 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653604740.05
    532 rdf:type schema:Person
    533 sg:person.0666455053.98 schema:affiliation grid-institutes:None
    534 schema:familyName Gray
    535 schema:givenName Kristian
    536 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666455053.98
    537 rdf:type schema:Person
    538 sg:person.0677171015.08 schema:affiliation grid-institutes:grid.412947.d
    539 schema:familyName Gusterson
    540 schema:givenName Barry A.
    541 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677171015.08
    542 rdf:type schema:Person
    543 sg:person.0744515657.65 schema:affiliation grid-institutes:None
    544 schema:familyName Edkins
    545 schema:givenName Sarah
    546 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744515657.65
    547 rdf:type schema:Person
    548 sg:person.0744552267.05 schema:affiliation grid-institutes:None
    549 schema:familyName Hughes
    550 schema:givenName Jaime
    551 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744552267.05
    552 rdf:type schema:Person
    553 sg:person.0762206722.62 schema:affiliation grid-institutes:None
    554 schema:familyName Palmieri
    555 schema:givenName Giuseppe
    556 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762206722.62
    557 rdf:type schema:Person
    558 sg:person.0775127652.18 schema:affiliation grid-institutes:grid.18886.3f
    559 schema:familyName Cooper
    560 schema:givenName Colin
    561 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775127652.18
    562 rdf:type schema:Person
    563 sg:pub.10.1038/313241a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052282285
    564 https://doi.org/10.1038/313241a0
    565 rdf:type schema:CreativeWork
    566 grid-institutes:None schema:alternateName Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton
    567 Institute of Molecular Genetics, C.N.R, Loc. Tramariglio, 07040, Alghero, Italy
    568 schema:name Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton
    569 Institute of Molecular Genetics, C.N.R, Loc. Tramariglio, 07040, Alghero, Italy
    570 rdf:type schema:Organization
    571 grid-institutes:grid.1049.c schema:alternateName Queensland Institute of Medical Research, RBH Post Office Herston, 4029, Queensland, Australia
    572 schema:name Queensland Institute of Medical Research, RBH Post Office Herston, 4029, Queensland, Australia
    573 rdf:type schema:Organization
    574 grid-institutes:grid.11450.31 schema:alternateName Department of Pathology, University of Sassari, Azienda USL1, 07100, Sassari, Italy
    575 schema:name Department of Pathology, University of Sassari, Azienda USL1, 07100, Sassari, Italy
    576 rdf:type schema:Organization
    577 grid-institutes:grid.18886.3f schema:alternateName Cancer Research UK Centre for Cell and Molecular Biology, Chester Beatty Labs, Institute of Cancer Research, SW3 6JB, London, UK
    578 Section of Cancer Genetics, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK
    579 Section of Molecular Carcinogenesis, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK
    580 Section of Paediatrics, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK
    581 schema:name Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, CB10 1SA, Hinxton
    582 Cancer Research UK Centre for Cell and Molecular Biology, Chester Beatty Labs, Institute of Cancer Research, SW3 6JB, London, UK
    583 Section of Cancer Genetics, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK
    584 Section of Molecular Carcinogenesis, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK
    585 Section of Paediatrics, Institute of Cancer Research, SM2 5NG, Sutton, Surrey, UK
    586 rdf:type schema:Organization
    587 grid-institutes:grid.412947.d schema:alternateName Department of Pathology, Western Infirmary, University of Glasgow, S11 6NT, UK
    588 schema:name Department of Pathology, Western Infirmary, University of Glasgow, S11 6NT, UK
    589 rdf:type schema:Organization
    590 grid-institutes:grid.414179.e schema:alternateName Department of Pathology, Duke University Medical Centre, 27710, Durham, North Carolina, USA
    591 Department of Surgery, Duke University Medical Centre, 27710, Durham, North Carolina, USA
    592 schema:name Department of Pathology, Duke University Medical Centre, 27710, Durham, North Carolina, USA
    593 Department of Surgery, Duke University Medical Centre, 27710, Durham, North Carolina, USA
    594 Royal Free & University College Medical School, WC1E 6JJ, London, UK
    595 rdf:type schema:Organization
    596 grid-institutes:grid.415550.0 schema:alternateName Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Hong Kong
    597 Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong
    598 schema:name Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Hong Kong
    599 Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong
    600 rdf:type schema:Organization
    601 grid-institutes:grid.439338.6 schema:alternateName Royal Brompton Hospital, SW3 6NP, London, UK
    602 schema:name Royal Brompton Hospital, SW3 6NP, London, UK
    603 rdf:type schema:Organization
    604 grid-institutes:grid.516138.8 schema:alternateName Abramson Family Cancer Research Institute, University of Pennsylvania Cancer Center, 19104, Philadelphia, Pennsylvania, USA
    605 schema:name Abramson Family Cancer Research Institute, University of Pennsylvania Cancer Center, 19104, Philadelphia, Pennsylvania, USA
    606 rdf:type schema:Organization
    607 grid-institutes:grid.5685.e schema:alternateName Department of Biology, YCR Cancer Research Unit, University of York, YO10 5YW, York, UK
    608 schema:name Department of Biology, YCR Cancer Research Unit, University of York, YO10 5YW, York, UK
    609 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...